MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Connecting digital mobility outcomes with clinical assessments in disorders such as Parkinson’s disease: the Mobilise-D study

W. Maetzler, A. Yarnall, I. Neatrour, A. Nieuwboer, B. Caulfield, A. Mirelman, C. Schlenstedt, C. Hansen, H. Gaßner, M. Jackson, F. Kluge, D. Berg, J. Hausdorff, J. Klucken, L. Granovsky, K. Emmert, R. Roubenoff, C. Becker, L. Rochester (Kiel, Germany)
Contribution of coding/noncoding variants in NUS1 to late-onset sporadic Parkinson’s disease

L. Jiang, H. Pan, Y. Zhao, Q. Zeng, Z. Liu, Q. Sun, Q. Xu, J. Tan, X. Yan, J. Li, B. Tang, J. Guo (Changsha, China)
Convolutional neural network for discriminating between Multiple System Atrophy and Healthy Control, comparing MRI modalities and highlighting the disease signature

E. Villain, F. Nemmi, A. Pavy-Le Traon, W. Meissner, O. Rascol, M.V Le Lann, X. Franceries, P. Péran (Toulouse, France)
Cooper-deficiency myeloneuropathy in Wilson´s Disease as a result of D-penicillamine treatment: A case report

A. Gomes, F. Rolim, K. Menezes, L. Brito, A. Moura, J. Lima, A. Marinho, G. Ferreira, F. Carvalho (Fortaleza, Brazil)
Copper induced neurobehavioral features of Parkinson’s disease and oxidative stress and their abatement by Eugenol

A. Kumar, B. Sharma (Allahabad, India)
Correlation and comparison of the lipid profile and the body fat mass in people with Parkinson’s disease submitted to three physical therapies

A.F Fagundes, E.M Monteiro, M.C Casal, M.D Delabary, A.Z Zanardi, F.B Boeno, S.M Munhoz, R.M de Menezes, A.O de Oliveira, F.M Martinez, L.T Tartaruga, A.H Haas (Porto Alegre, Brazil)
Correlation Between Dyskinesia and Quality of Life at Baseline and After 12 months of Treatment with LCIG in Patients with Advanced Parkinson’s Disease

J. L Aldred, F. E Pontieri, L. Bergmann, T. Gao, P. Kukreja, P. Bourgeois, N. Kovács (Spokane, WA, USA)
Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease

K. Eguchi, I. Yabe, S. Shirai, M. Matsushima, T. Kano, K. Yamazaki, S. Hamauchi, T. Sasamori, K. Hirata, T. Seki, M. Kitagawa, M. Otsuki, T. Shiga, K. Hokin, H. Sasaki (Sapporo, Japan)
Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease

Y.S Kim, S.M Kim, H.W Shin, Y.C Youn, S.W Kang (Seoul, Republic of Korea)
Correlation of Lead Location with Clinical Outcomes in a Double-Blinded Randomized Controlled Trial Evaluating Subthalamic Deep Brain Stimulation in Parkinson’s Disease (INTREPID)

J. Vitek, R. Jain, R. Woon, L. Chen, P. Starr (Minneapolis, MN, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z